Product Images Doxazosin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Doxazosin NDC 42291-259 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label 2mg 2015 04 09 at 10.41.29 AM
AVKARE is a pharmaceutical company that produces Doxazosin Tablets, USP which come in a pack of 1000 tablets with the imprint R on them. The National Drug Code for this medication is 42291-258-10.*
Label 4mg 2015 04 09 at 10.42.43 AM
Label 8mg 2015 04 09 at 10.43.48 AM
doxazosin-structure - doxazosin structure
figure1
table3
This is a summary of effectiveness data from placebo-controlled trials for the treatment of Benign Prostatic Hyperplasia (BPH). The data includes changes in the maximum flow rate (mL/sec) and symptom score. The results show that doxazosin at both 4mg and 8mg doses improved these measures when compared to placebo. Additionally, the Modified Boyarsky Questionnaire was administered in Study 2. Change was measured at endpoint and at fixed-dose efficacy phase, 2-6 hours post-dose depending on the study. Study 1 is focused on hypertensives with BPH and 35 patients received an 8mg dose of doxazosin. Statistically significant improvements were observed with both doses of doxazosin compared to placebo.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.